Ian Tannock
Dr. Tannock is Emeritus Professor at Princess Margaret Cancer Centre and University of Toronto. His PhD is from the Institute of Cancer Research, London, England and his MD from University of Pennsylvania, Philadelphia, USA. His clinical expertise is in GU and breast cancer, and he chaired trials for men with metastatic prostate cancer that led to licencing of drugs worldwide. Dr. Tannock was editor of the Basic Science of Oncology textbook, now in its 6th edition (2021), used by trainees in all branches of oncology.
Dr. Tannock was a member of the ASCO Board of Directors (2001-2004), and of the EORTC Board (2009-2016). He received the ESMO award (2012), the ASCO Allen Lichter award for leadership and innovation (2019), holds 2 honorary degrees and is appointed to the Order of Canada.
Since retiring from active practice, Dr Tannock mentors young oncologists internationally, and authors papers relating to clinical trial methodology. He is a founding member of Common-Sense Oncology. These initiatives seek to return cancer management and cancer trials to evidence-based benefit for patients, and thereby reduce cost and improve global access to effective cancer treatment.
